Not Yet Recruiting
A Phase I Trial of QLS2313 Injection in Relapsed/Refractory Hematological Malignancies
NCT07294300
- Conditions
- Hematologic Diseases, Hematologic Neoplasms, Hemic and Lymphatic Diseases, +3 more
- Locations
-
- Shanghai Jiaotong University School of Medicine Ruijin Hospital Shanghai, Shanghai Municipality, China